@article{Kunzmann2022,
author = {Kevin Kunzmann and Michael J. Grayling and Kim May Lee and David S. Robertson and Kaspar Rufibach and James M. S. Wason},
title = {A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials},
journal = {The American Statistician},
volume = {75},
number = {4},
pages = {424-432},
year  = {2021},
publisher = {Taylor & Francis},
doi = {10.1080/00031305.2021.1901782},
URL = {https://doi.org/10.1080/00031305.2021.1901782},
eprint = {https://doi.org/10.1080/00031305.2021.1901782 }}

@book{Held2020,
   author = {Leonhard Held and Daniel Sabanés Bové},
   city = {Berlin, Heidelberg},
   doi = {10.1007/978-3-662-60792-3},
   isbn = {978-3-662-60791-6},
   publisher = {Springer Berlin Heidelberg},
   title = {Likelihood and Bayesian Inference},
   year = {2020},
}

@book{Spiegelhalter2003,
   author = {David J. Spiegelhalter and Keith R. Abrams and Jonathan P. Myles},
   doi = {10.1002/0470092602},
   isbn = {9780471499756},
   month = {12},
   publisher = {Wiley},
   title = {Bayesian Approaches to Clinical Trials and Health‐Care Evaluation},
   year = {2003},
}

@article{Baumgartner2020,
   author = {Christine Baumgartner and Frederikus A Klok and Marc Carrier and Andreas Limacher and Jeanne Moor and Marc Righini and Jürg-Hans Beer and Martina Peluso and Damiana Rakovic and Menno V Huisman and Drahomir Aujesky},
   doi = {10.1136/bmjopen-2020-040151},
   issn = {2044-6055},
   issue = {11},
   journal = {BMJ Open},
   month = {11},
   pages = {e040151},
   title = {Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: protocol for a multicentre randomised placebo-controlled non-inferiority trial (SAFE-SSPE)},
   volume = {10},
   year = {2020},
}

@article{Rufibach2016,
   author = {Kaspar Rufibach and Hans Ulrich Burger and Markus Abt},
   doi = {10.1002/pst.1764},
   issn = {15391604},
   issue = {5},
   journal = {Pharmaceutical Statistics},
   month = {9},
   pages = {438-446},
   title = {Bayesian predictive power: choice of prior and some recommendations for its use as probability of success in drug development},
   volume = {15},
   year = {2016},
}

@article{OHagan2005,
   author = {Anthony O'Hagan and John W. Stevens and Michael J. Campbell},
   doi = {10.1002/pst.175},
   issn = {1539-1604},
   issue = {3},
   journal = {Pharmaceutical Statistics},
   month = {7},
   pages = {187-201},
   title = {Assurance in clinical trial design},
   volume = {4},
   year = {2005},
}

@book{Grieve2022,
   author = {Andrew P. Grieve},
   city = {Boca Raton},
   doi = {10.1201/9781003218531},
   isbn = {9781003218531},
   month = {4},
   publisher = {Chapman and Hall/CRC},
   title = {Hybrid Frequentist/Bayesian Power and Bayesian Power in Planning Clinical Trials},
   year = {2022},
}

@book{Gelman2013,
   author = {Andrew Gelman and John B. Carlin and Hal S. Stern and David B. Dunson and Aki Vehtari and Donald B. Rubin},
   doi = {10.1201/b16018},
   isbn = {9780429113079},
   month = {11},
   publisher = {Chapman and Hall/CRC},
   title = {Bayesian Data Analysis},
   year = {2013},
}

@article{Stefan2019,
   author = {Angelika M. Stefan and Quentin F. Gronau and Felix D. Schönbrodt and Eric-Jan Wagenmakers},
   doi = {10.3758/s13428-018-01189-8},
   issn = {1554-3528},
   issue = {3},
   journal = {Behavior Research Methods},
   month = {6},
   pages = {1042-1058},
   title = {A tutorial on Bayes Factor Design Analysis using an informed prior},
   volume = {51},
   year = {2019},
}

@article{Agresti2000,
   author = {Alan Agresti and Brian Caffo},
   doi = {10.2307/2685779},
   issn = {00031305},
   issue = {4},
   journal = {The American Statistician},
   month = {11},
   pages = {280},
   title = {Simple and Effective Confidence Intervals for Proportions and Differences of Proportions Result from Adding Two Successes and Two Failures},
   volume = {54},
   year = {2000},
}

@article{Agresti2005,
   author = {Alan Agresti and Yongyi Min},
   doi = {10.1111/j.1541-0420.2005.031228.x},
   issn = {0006341X},
   issue = {2},
   journal = {Biometrics},
   month = {6},
   pages = {515-523},
   title = {Frequentist Performance of Bayesian Confidence Intervals for Comparing Proportions in 2 × 2 Contingency Tables},
   volume = {61},
   year = {2005},
}

@article{Grieve2016,
   author = {Andrew P. Grieve},
   doi = {10.1002/pst.1736},
   issn = {15391604},
   issue = {2},
   journal = {Pharmaceutical Statistics},
   month = {3},
   pages = {96-108},
   title = {Idle thoughts of a ‘well-calibrated’ Bayesian in clinical drug development},
   volume = {15},
   year = {2016},
}

@article{Altham1969,
   author = {Patricia M. E. Altham},
   doi = {10.1111/j.2517-6161.1969.tb00786.x},
   issn = {00359246},
   issue = {2},
   journal = {Journal of the Royal Statistical Society: Series B (Methodological)},
   month = {7},
   pages = {261-269},
   title = {Exact Bayesian Analysis of a 2 Times 2 Contingency Table, and Fisher's “Exact” Significance Test},
   volume = {31},
   year = {1969},
}

@article{Muirhead2013,
   author = {Robb J. Muirhead and Adina I. Şoaita},
   doi = {10.1214/12-IMSCOLL1007},
   pages = {126-137},
   title = {On an Approach to Bayesian Sample Sizing in Clinical Trials},
   year = {2013},
}
